LAURUSLABS.NS Balance Sheet
Laurus Labs Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:35
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹30.16 Bn | ₹34.46 Bn | ₹36.68 Bn | ₹38.73 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹5.51 Bn | ₹4.23 Bn | ₹4.58 Bn | ₹7.73 Bn | CapitalWorkInProgress |
| Goodwill | ₹2.46 Bn | ₹2.46 Bn | ₹2.46 Bn | ₹2.46 Bn | Goodwill |
| Other Intangible Assets | ₹0.13 Bn | ₹0.19 Bn | ₹0.19 Bn | ₹0.18 Bn | OtherIntangibleAssets |
| Non-current Investments | ₹0.50 Bn | ₹1.24 Bn | ₹2.33 Bn | ₹3.09 Bn | NoncurrentInvestments |
| Other Non-current Assets | ₹1.20 Bn | ₹0.65 Bn | ₹3.22 Bn | ₹4.15 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | ₹41.99 Bn | ₹45.52 Bn | ₹50.03 Bn | ₹56.82 Bn | NoncurrentAssets |
| Inventories | ₹16.85 Bn | ₹18.45 Bn | ₹19.37 Bn | ₹23.42 Bn | Inventories |
| Trade Receivables | ₹15.80 Bn | ₹16.63 Bn | ₹20.07 Bn | ₹21.55 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹0.46 Bn | ₹1.39 Bn | ₹1.00 Bn | ₹1.13 Bn | CashAndCashEquivalents |
| Current Investments | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | CurrentInvestments |
| Other Current Assets | ₹1.31 Bn | ₹1.75 Bn | ₹2.38 Bn | ₹2.14 Bn | OtherCurrentAssets |
| Total Current Assets | ₹34.62 Bn | ₹38.35 Bn | ₹43.32 Bn | ₹48.29 Bn | CurrentAssets |
| Total Assets | ₹76.60 Bn | ₹83.87 Bn | ₹93.36 Bn | ₹105.11 Bn | Assets |
| Equity Share Capital | ₹1.08 Bn | ₹1.08 Bn | ₹1.08 Bn | ₹1.08 Bn | EquityShareCapital |
| Other Equity | ₹39.30 Bn | ₹40.03 Bn | ₹43.65 Bn | ₹51.92 Bn | OtherEquity |
| Equity Attributable to Owners | ₹40.38 Bn | ₹41.11 Bn | ₹44.73 Bn | ₹53.00 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹0.11 Bn | ₹0.05 Bn | ₹1.30 Bn | ₹1.31 Bn | NonControllingInterest |
| Total Equity | ₹40.49 Bn | ₹41.16 Bn | ₹46.03 Bn | ₹54.31 Bn | Equity |
| Long-term Borrowings | ₹7.61 Bn | ₹7.98 Bn | ₹6.46 Bn | ₹6.11 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹11.79 Bn | ₹11.59 Bn | ₹11.93 Bn | ₹14.44 Bn | NoncurrentLiabilities |
| Short-term Borrowings | ₹12.11 Bn | ₹17.09 Bn | ₹20.48 Bn | ₹17.86 Bn | BorrowingsCurrent |
| Trade Payables | ₹7.11 Bn | ₹10.51 Bn | ₹9.58 Bn | ₹12.52 Bn | TradePayablesCurrent |
| Other Current Liabilities | ₹2.28 Bn | ₹1.44 Bn | ₹1.01 Bn | ₹1.62 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | ₹24.32 Bn | ₹31.12 Bn | ₹35.40 Bn | ₹36.35 Bn | CurrentLiabilities |
| Total Equity and Liabilities | ₹76.60 Bn | ₹83.87 Bn | ₹93.36 Bn | ₹105.11 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from LAURUSLABS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).